AI Disease Screening Solution
AIVITA AMG
Large NGS Panel
Driving the Future of Precision Medicine
With outstanding automated workflows, AI-driven analysis, and high-performance equipment, we elevate cancer screening and personalized treatment to new heights, providing medical institutions and patients with a faster, more accurate, and standardized testing experience.
Illumina's NGS platform has become the gold standard in genetic testing, capable of detecting even the smallest genetic variations to provide scientific evidence for cancer risk assessment and treatment decision-making. However, genetic testing requires more than a single technology. Enhancing testing efficiency, reducing human error, and accelerating report generation are critical challenges.
Illumina's NGS platform has become the gold standard in genetic testing, capable of detecting even the smallest genetic variations to provide scientific evidence for cancer risk assessment and treatment decision-making. However, genetic testing requires more than a single technology. Enhancing testing efficiency, reducing human error, and accelerating report generation are critical challenges.
AIVITA AMG Features
52% Reduction in Testing Time
%20(1).png)
50% Less Workforce Requirement
99% Accuracy Improvement
%20(1).png)
Supports Large NGS Panels
AIVITA AMG Workflow
%20(1).png)
The AIVITA AMG Workflow optimizes the genetic testing process through automation, covering sample processing, nucleic acid extraction, library preparation, gene sequencing, and data analysis. Automated nucleic acid extractors, liquid handling systems, and library purification machines enhance testing accuracy and efficiency. The workflow supports cancer and genetic disease screening with the BRCA Screening Kit and Illumina TSO 500, while quality control is ensured through Quantus and Qseq100, verifying DNA sample standards. Finally, DataSense integrates sequencing data to ensure accuracy and generate reliable clinical reports.
AIVITA AMG Components
MIC Automated equipment
Equipped with three key machines— NucleoXtract, LiquiXpert and PuriXcel—this setup minimizes manual labor, standardizes operations, and enhances testing efficiency.
Screening Kits
Compatible with the domestically developed BRCA Screening Kit by Biomedica and Illumina TSO 500, enabling full-process automation from sample processing to genetic analysis.
X1 Sequencing
Integrating genetic sequencing with intelligent analysis, X1 Sequencing enables fully automated report generation. It rapidly interprets NGS data, accurately identifies genetic variations, and provides personalized treatment recommendations.
DataSense
With high-performance, powerful, and scalable computing capabilities, DataSense features built-in data synchronization to ensure secure in-lab data storage, preventing external risks.